Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Ibuprofen may protect against development of Parkinson's disease

New research suggests that ibuprofen may offer protection against developing Parkinson's disease, according to one of the largest studies to date investigating the possible benefits of the over-the-counter drug on the disease. The study is published in the March 2, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Mar 2011

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Everyone knows someone that has been touched by cancer. Over one and a half million Americans will be diagnosed with some form of cancer in 2011, and more than 560,000 will die from the disease, accounting for 1 out of every 5 deaths.

2 Mar 2011

Study: Light-to-moderate alcohol consumption may decrease risk of dementia

Experts agree that long-term alcohol abuse is detrimental to memory function and can cause neuro-degenerative disease. However, according to a study published in Age and Ageing by Oxford University Press today, there is evidence that light-to-moderate alcohol consumption may decrease the risk of cognitive decline or dementia.

2 Mar 2011

Mathematical model predicts lifespan of stem cells

When patients receive a bone marrow transplant, they are getting a new population of hematopoietic stem cells. Fresh stem cells are needed when a patient is low on red blood cells, as in anemia, or white blood cells, which can be caused by cancer or even cancer treatments such as irradiation or chemotherapy. The problem is that a bone marrow transplant might not succeed because the transplanted stem cells don't live long enough or because they proliferate too well, leading to leukemia.

2 Mar 2011

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

An experimental drug that targets a brain system that controls inflammation might help preserve neurological function in people who survive sudden cardiac arrest, new research suggests.

2 Mar 2011

New study: Alzheimer's disease can be inherited from your mother than father

Results from a new study contribute to growing evidence that if one of your parents has Alzheimer's disease, the chances of inheriting it from your mother are higher than from your father.

1 Mar 2011

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals for the development of an active vaccination programme against Alzheimer's disease.

1 Mar 2011

New nasal vaccine holds promise against both Alzheimer's disease and stroke

One in eight Americans will fall prey to Alzheimer's disease at some point in their life, current statistics say. Because Alzheimer's is associated with vascular damage in the brain, many of them will succumb through a painful and potentially fatal stroke.

1 Mar 2011

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.

28 Feb 2011

biOasis completes selection of monoclonal antibodies in Cognitest program for Alzheimer's disease

biOasis Technologies Inc. is pleased to announce the completion of a project intended to produce proprietary monoclonal antibodies (mAbs) for its Cognitest™ blood test for Alzheimer's disease.

28 Feb 2011

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA, using Selcia's fragment screening technology. Novel and weak affinity hits were identified from Selcia's Fragment Library, using their proprietary CEfrag technique.

28 Feb 2011

New study: Black elders seem to have protective effect against hearing loss

Nearly two-thirds of Americans age 70 and older have hearing loss, but those who are of black race seem to have a protective effect against this loss, according to a new study led by Johns Hopkins and National Institute on Aging researchers.

28 Feb 2011

Study: Storytelling program improves communication skills, positive affect in persons with dementia

Nearly 16 million Americans will be diagnosed with Alzheimer's disease or another type of dementia by 2050, according to the Alzheimer's Association. Symptoms include mood and behavior changes, disorientation, memory loss and difficulty walking and speaking.

28 Feb 2011

Nation wide aged care deficits surface in report

According to an Access Economics study parts of the country have the worst projected shortfalls in aged care beds and community care packages. The study has predicted that a nationwide shortfall of 279,000 places needed to care for the elderly and infirm in 40 years’ time, with the lack concentrated on the most populous states of NSW and Victoria.

27 Feb 2011

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."

25 Feb 2011

Longer looks: Best health policy picks from thought-provoking publications

Last week, in the largest nationwide bust of its kind ever, more than 700 federal agents fanned out from Miami to Los Angeles and rounded up 111 doctors, nurses, physical therapists and health company executives in nine cities.

25 Feb 2011

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.

25 Feb 2011

Researchers to share information on delirium at ADS conference

At least seven million hospitalized Americans suffer from delirium each year, however the condition goes unrecognized in more than 60 percent of patients. Even if diagnosed, there is no effective way to treat the condition, which is a growing concern to medical professionals.

25 Feb 2011

New research: Alzheimer's disease may be easily misdiagnosed in elder people

New research shows that Alzheimer's disease and other dementing illnesses may be easily misdiagnosed in the elderly, according to early results of a study of people in Hawaii who had their brains autopsied after death. The research is being released today and will be presented as part of a plenary session at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

23 Feb 2011

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Ibuprofen may protect against development of Parkinson's disease

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Study: Light-to-moderate alcohol consumption may decrease risk of dementia

Mathematical model predicts lifespan of stem cells

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Experimental drug may help preserve neurological function in survivors of sudden cardiac arrest

New study: Alzheimer's disease can be inherited from your mother than father

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

New nasal vaccine holds promise against both Alzheimer's disease and stroke

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

biOasis completes selection of monoclonal antibodies in Cognitest program for Alzheimer's disease

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

New study: Black elders seem to have protective effect against hearing loss

Study: Storytelling program improves communication skills, positive affect in persons with dementia

Nation wide aged care deficits surface in report

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

Longer looks: Best health policy picks from thought-provoking publications

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Researchers to share information on delirium at ADS conference

New research: Alzheimer's disease may be easily misdiagnosed in elder people

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in